Sign Up to like & get
recommendations!
0
Published in 2020 at "Circulation"
DOI: 10.1161/circ.142.suppl_3.16292
Abstract: Introduction: Platelet activation, by adenosine diphosphate (ADP) via P2Y12 receptors and thrombin via PAR1 and PAR4, is a key therapeutic target in cardiovascular disease (CVD). The efficacy of an...
read more here.
Keywords:
par4;
16292 selective;
receptor;
selective platelet ... See more keywords